Expert Ratings for BioNTech
Portfolio Pulse from Benzinga Insights
BioNTech (NASDAQ:BNTX) has received 15 analyst ratings in the last quarter, with 6 being bullish and 9 indifferent. The average price target is $142.13, indicating an upside from the current price of $117.61. The average price target has increased by 4.68% over the past month.
August 28, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioNTech has received mostly bullish and indifferent ratings from analysts, with an average price target indicating an upside.
The majority of the analyst ratings for BioNTech are bullish or indifferent, indicating a generally positive outlook for the company. The average price target is higher than the current price, suggesting that analysts believe the stock price will increase in the future. This could potentially have a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100